TSHA icon

Taysha Gene Therapies
TSHA

Overview Fund Activity

71 hedge funds and large institutions have $111M invested in Taysha Gene Therapies in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
71
Holders Change
+6
Holders Change %
+9.23%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
27
Reduced
15
Closed
9
Calls
$108K
Puts
$163K
Net Calls
-$55K
Net Calls Change
-$55K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
$1.63M
2
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$2.87M
3
Citadel Advisors
Citadel Advisors
Florida
$1.36M
4
Vanguard Group
Vanguard Group
Pennsylvania
$6.6M
5
Two Sigma Investments
Two Sigma Investments
New York
$1.19M

Top Sellers

1
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$0
2
Fidelity Investments
Fidelity Investments
Massachusetts
$21.5M
3
BlackRock
BlackRock
New York
$14.3M
4
NCM
Nantahala Capital Management
Connecticut
$8.7M
5
Millennium Management
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
MIM
76
MetLife Investment Management
New Jersey
– -$111K -9,509 Closed
MLICM
77
Metropolitan Life Insurance Company (MetLife)
New York
– -$84.8K -7,280 Closed
US Bancorp
78
US Bancorp
Minnesota
– -$6K -524 Closed
PA
79
Parallel Advisors
California
– -$1K -45 Closed
1 2 3
4